BELLEROPHON THERAPEUTICS INC's ticker is BLPH and the CUSIP is 078771300.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $24 | -54.7% | 59,499 | -23.0% | 0.00% | – |
| Q2 2023 | $53 | -96.0% | 77,299 | -54.5% | 0.00% | -100.0% |
| Q1 2023 | $1,341 | +765.2% | 169,899 | -1.1% | 0.00% | – |
| Q4 2022 | $155 | -99.9% | 171,799 | -12.4% | 0.00% | – |
| Q3 2022 | $214,000 | -17.1% | 196,191 | -6.3% | 0.00% | – |
| Q2 2022 | $258,000 | -41.0% | 209,399 | +13.0% | 0.00% | -100.0% |
| Q1 2022 | $437,000 | -21.3% | 185,299 | +3.6% | 0.00% | 0.0% |
| Q4 2021 | $555,000 | -32.2% | 178,899 | -11.3% | 0.00% | 0.0% |
| Q3 2021 | $819,000 | -34.2% | 201,706 | -21.5% | 0.00% | -50.0% |
| Q2 2021 | $1,244,000 | +2.6% | 257,072 | +10.0% | 0.00% | 0.0% |
| Q1 2021 | $1,213,000 | -15.1% | 233,799 | +9.1% | 0.00% | 0.0% |
| Q4 2020 | $1,429,000 | -43.5% | 214,299 | -13.7% | 0.00% | -33.3% |
| Q3 2020 | $2,528,000 | -32.4% | 248,311 | -16.7% | 0.00% | 0.0% |
| Q2 2020 | $3,741,000 | +128.8% | 298,111 | +99.8% | 0.00% | +50.0% |
| Q1 2020 | $1,635,000 | – | 149,181 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Puissance Capital Management LP | 1,153,846 | $14,481,000 | 61.82% |
| Telemetry Investments, L.L.C. | 125,000 | $1,569,000 | 4.26% |
| NEW MOUNTAIN VANTAGE ADVISERS, L.L.C. | 1,009,231 | $12,666,000 | 0.60% |
| Boxer Capital, LLC | 98,809 | $1,240,000 | 0.06% |
| RPg Family Wealth Advisory, LLC | 3,000 | $37,650,000 | 0.02% |
| DAVENPORT & Co LLC | 107,150 | $1,345,000 | 0.02% |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | 25,400 | $319,000 | 0.01% |
| ExodusPoint Capital Management, LP | 16,500 | $207,000 | 0.01% |
| Renaissance Technologies | 298,111 | $3,741,000 | 0.00% |
| Financial Architects, Inc | 200 | $3,000 | 0.00% |